192 related articles for article (PubMed ID: 19776078)
1. Protective effect of N-glycan bisecting GlcNAc residues on beta-amyloid production in Alzheimer's disease.
Akasaka-Manya K; Manya H; Sakurai Y; Wojczyk BS; Kozutsumi Y; Saito Y; Taniguchi N; Murayama S; Spitalnik SL; Endo T
Glycobiology; 2010 Jan; 20(1):99-106. PubMed ID: 19776078
[TBL] [Abstract][Full Text] [Related]
2. Introduction of bisecting GlcNAc in N-glycans of adenylyl cyclase III enhances its activity.
Li W; Takahashi M; Shibukawa Y; Yokoe S; Gu J; Miyoshi E; Honke K; Ikeda Y; Taniguchi N
Glycobiology; 2007 Jun; 17(6):655-62. PubMed ID: 17324955
[TBL] [Abstract][Full Text] [Related]
3. Beta1,6-N-acetylglucosamine-bearing N-glycans in human gliomas: implications for a role in regulating invasivity.
Yamamoto H; Swoger J; Greene S; Saito T; Hurh J; Sweeley C; Leestma J; Mkrdichian E; Cerullo L; Nishikawa A; Ihara Y; Taniguchi N; Moskal JR
Cancer Res; 2000 Jan; 60(1):134-42. PubMed ID: 10646865
[TBL] [Abstract][Full Text] [Related]
4. GLP-1 receptor agonists downregulate aberrant GnT-III expression in Alzheimer's disease models through the Akt/GSK-3β/β-catenin signaling.
Wang Y; Chen S; Xu Z; Chen S; Yao W; Gao X
Neuropharmacology; 2018 Mar; 131():190-199. PubMed ID: 29223528
[TBL] [Abstract][Full Text] [Related]
5. Bisecting GlcNAc modification stabilizes BACE1 protein under oxidative stress conditions.
Kizuka Y; Nakano M; Kitazume S; Saito T; Saido TC; Taniguchi N
Biochem J; 2016 Jan; 473(1):21-30. PubMed ID: 26467158
[TBL] [Abstract][Full Text] [Related]
6. Bisecting GlcNAc mediates the binding of annexin V to Hsp47.
Gao CX; Miyoshi E; Uozumi N; Takamiya R; Wang X; Noda K; Gu J; Honke K; Wada Y; Taniguchi N
Glycobiology; 2005 Nov; 15(11):1067-75. PubMed ID: 16000695
[TBL] [Abstract][Full Text] [Related]
7. beta1,4-N-Acetylglucosaminyltransferase III potentiates beta1 integrin-mediated neuritogenesis induced by serum deprivation in Neuro2a cells.
Shigeta M; Shibukawa Y; Ihara H; Miyoshi E; Taniguchi N; Gu J
Glycobiology; 2006 Jun; 16(6):564-71. PubMed ID: 16531477
[TBL] [Abstract][Full Text] [Related]
8. Neural functions of bisecting GlcNAc.
Kizuka Y; Taniguchi N
Glycoconj J; 2018 Aug; 35(4):345-351. PubMed ID: 29909448
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of bisecting N-acetylglucosaminyltransferase-III gene in a human fetal hepatocyte cell line by hepatitis B virus.
Shim JK; Lee YC; Chung TH; Kim CH
J Gastroenterol Hepatol; 2004 Dec; 19(12):1374-87. PubMed ID: 15610311
[TBL] [Abstract][Full Text] [Related]
10. Hyperexpression of N-acetylglucosaminyltransferase-III in liver tissues of transgenic mice causes fatty body and obesity through severe accumulation of Apo A-I and Apo B.
Lee J; Song EY; Chung TW; Kang SK; Kim KS; Chung TH; Yeom YI; Kim CH
Arch Biochem Biophys; 2004 Jun; 426(1):18-31. PubMed ID: 15130779
[TBL] [Abstract][Full Text] [Related]
11. Bidirectional N-acetylglucosamine transfer mediated by beta-1,4-N-acetylglucosaminyltransferase III.
Okada T; Ihara H; Ito R; Taniguchi N; Ikeda Y
Glycobiology; 2009 Apr; 19(4):368-74. PubMed ID: 19095698
[TBL] [Abstract][Full Text] [Related]
12. Excess of nicastrin in brain results in heterozygosity having no effect on endogenous APP processing and amyloid peptide levels in vivo.
Brijbassi S; Amtul Z; Newbigging S; Westaway D; St George-Hyslop P; Rozmahel RF
Neurobiol Dis; 2007 Feb; 25(2):291-6. PubMed ID: 17071095
[TBL] [Abstract][Full Text] [Related]
13. Targeting BACE with small inhibitory nucleic acids - a future for Alzheimer's disease therapy?
Nawrot B
Acta Biochim Pol; 2004; 51(2):431-44. PubMed ID: 15218540
[TBL] [Abstract][Full Text] [Related]
14. Cell cycle-dependent regulation of N-acetylglucosaminyltransferase-III in a human colon cancer cell line, Colo201.
Kang R; Ikeda Y; Miyoshi E; Wang W; Li W; Ihara Y; Sheng Y; Taniguchi N
Arch Biochem Biophys; 2000 Feb; 374(1):52-8. PubMed ID: 10640395
[TBL] [Abstract][Full Text] [Related]
15. An aberrant sugar modification of BACE1 blocks its lysosomal targeting in Alzheimer's disease.
Kizuka Y; Kitazume S; Fujinawa R; Saito T; Iwata N; Saido TC; Nakano M; Yamaguchi Y; Hashimoto Y; Staufenbiel M; Hatsuta H; Murayama S; Manya H; Endo T; Taniguchi N
EMBO Mol Med; 2015 Feb; 7(2):175-89. PubMed ID: 25592972
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological evidences for DFK167-sensitive presenilin-independent gamma-secretase-like activity.
Sevalle J; Ayral E; Hernandez JF; Martinez J; Checler F
J Neurochem; 2009 Jul; 110(1):275-83. PubMed ID: 19457123
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of the N-glycans of human monoclonal immunoglobulins M produced by hybridoma and parental cells.
Fukuta K; Abe R; Yokomatsu T; Kono N; Nagatomi Y; Asanagi M; Shimazaki Y; Makino T
Arch Biochem Biophys; 2000 Jun; 378(1):142-50. PubMed ID: 10871054
[TBL] [Abstract][Full Text] [Related]
18. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
[TBL] [Abstract][Full Text] [Related]
19. Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi.
Xia W; Zhang J; Ostaszewski BL; Kimberly WT; Seubert P; Koo EH; Shen J; Selkoe DJ
Biochemistry; 1998 Nov; 37(47):16465-71. PubMed ID: 9843412
[TBL] [Abstract][Full Text] [Related]
20. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
